Engraftment of RH-positive marrow in a recipient with RH antibody.
D000208:Acute Disease; D000328:Adult; D001787:Blood Group Incompatibility; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002470:Cell Survival; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D006085:Graft Survival; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007278:Injections, Spinal; D007518:Isoantibodies; D007945:Leukemia, Lymphoid / Q000276:immunology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D010357:Patient Isolators; D012204:Rh-Hr Blood-Group System
D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System; D003561:Cytarabine; D003520:Cyclophosphamide; D006918:Hydroxyurea; D008727:Methotrexate